Intended for healthcare professionals

Rapid response to:

Clinical Review State of the Art Review

How to use biologic agents in patients with rheumatoid arthritis who have comorbid disease

BMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h3658 (Published 17 August 2015) Cite this as: BMJ 2015;351:h3658

Chinese translation

该文章的中文翻译

Rapid Response:

Re: How to use biologic agents in patients with rheumatoid arthritis who have comorbid disease

Rheumatoid arthritis (RA) is reported to be a type of autoimmune disorder with a genetic predisposition and to an extent reported to be more common in females. The treatment in some RA patients associated with co-morbid diseases needs to be left to the clinical acumen of the practising physicians. Though we live in the days of Evidence Medicine, certain types of patients need to adopt their treatment schedule taking into consideration what treatment is more important - say, to treat the co-morbid condition or RA. In some of these disorders one needs to remind the patient that the mind can make a heaven or hell out of a condition.

A patient with such a mixed ailment needs to evolve a life style adjusted to therapy and need to learn by trial and error.

Sometimes a combination therapy of like naturopathy with allopathy could be adopted.

Therapy is unique to every individual, and genomic medicine could be an answer we are searching for.

Competing interests: No competing interests

19 August 2015
Dhastagir Sultan Sheriff
Professor
Melmaruvathur Adhiparasakthi Institute of Medical Sciences and Research
Melmaruvathur,India